These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23069229)

  • 1. [Bleedings during vitamin K antagonist therapy associated with ciclosporin and rifampicin].
    Chouchana L; Languille E; Weiss N; Billaud EM; Lillo-Le Louet A
    Presse Med; 2013 May; 42(5):908-11. PubMed ID: 23069229
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of the efficacy of a low dose of antivitamin K and a preventive dose of low molecular weight heparin in the prevention of relapses of deep venous thrombosis after curative treatment in the aged subject].
    Pistorius MA; Said L; Planchon B
    J Mal Vasc; 1994; 19(1):68. PubMed ID: 8027686
    [No Abstract]   [Full Text] [Related]  

  • 3. Bleedings induced by oral anticoagulants: a study of adverse drug reactions reported to Midi-Pyrénées PharmacoVigilance Centre between 2003 and 2006.
    Boudal P; Sommet A; Bagheri H; Pathak A; Montastruc JL
    Therapie; 2010; 65(6):567-9. PubMed ID: 21176763
    [No Abstract]   [Full Text] [Related]  

  • 4. Case report: sirolimus associated interstitial lung disease.
    Sajjad I; Murthy MH; Nazir J; Santella RN
    S D Med; 2006 Nov; 59(11):467-9, 471. PubMed ID: 17180843
    [No Abstract]   [Full Text] [Related]  

  • 5. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).
    Daveluy A; Géniaux H; Thibaud L; Mallaret M; Miremont-Salamé G; Haramburu F
    Therapie; 2014; 69(6):519-20. PubMed ID: 25230280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.
    Béné J; Dubart AE; Senis C; Auffret M; Caron J; Gautier S
    J Mal Vasc; 2014 Jul; 39(4):248-55. PubMed ID: 24889788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of adequate anticoagulant therapy and its complications.
    Royston GR
    Vasc Dis; 1966 Oct; 3(5):295-304. PubMed ID: 4162445
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 9. Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.
    Gaertner S; Cordeanu EM; Mirea C; Stephan D
    Int J Cardiol; 2015; 186():141-2. PubMed ID: 25818758
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
    Chapman JR; Nankivell BJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute toxic myopathy due to pyrazinamide in a patient with renal transplantation and cyclosporine therapy.
    Fernández-Solà J; Campistol JM; Miró O; Garcés N; Soy D; Grau JM
    Nephrol Dial Transplant; 1996 Sep; 11(9):1850-2. PubMed ID: 8918638
    [No Abstract]   [Full Text] [Related]  

  • 12. [No indication of a higher risk of severe gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulant].
    Zechmann S
    Praxis (Bern 1994); 2016 Jan; 105(2):109-10. PubMed ID: 26787335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute interstitial nephritis of fluindione: about three cases].
    Beauchamp C; Enache I; Haskour A; Martin L
    Nephrol Ther; 2008 Oct; 4(5):339-46. PubMed ID: 18417438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Necrotic leg ulcers induced by vitamin K antagonists: five cases].
    Bezier M; Perceau G; Reguiai Z; Remy-Leroux V; Tchen T; Durlach A; Grange F; Nguyen P; Bernard P
    Ann Dermatol Venereol; 2011 Oct; 138(10):657-63. PubMed ID: 21978501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulant treatment of thromboses, a long term treatment].
    Flessinger JN
    Soins; 2006 Jun; (706):36-7. PubMed ID: 16821405
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].
    Martínez M; González Roncero FM; López M; Toro J; Valdivia MA; Pereira P; Gentil MA; Rodríguez Algarra G; Mateos J
    Nefrologia; 2004; 24 Suppl 3():7-10. PubMed ID: 15219060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idraparinux versus standard therapy for venous thromboembolic disease.
    ; Buller HR; Cohen AT; Davidson B; Decousus H; Gallus AS; Gent M; Pillion G; Piovella F; Prins MH; Raskob GE
    N Engl J Med; 2007 Sep; 357(11):1094-104. PubMed ID: 17855670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Accidents caused by anticoagulants].
    Gruel Y; Maakaroun A
    Rev Prat; 2002 Nov; 52(17):1929-35. PubMed ID: 12532872
    [No Abstract]   [Full Text] [Related]  

  • 20. Paradoxical venous limb gangrene complicating oral anticoagulation in a patient with cancer-associated deep venous thrombosis.
    Georgin S; Pouchot J; Raschilas F; Barete S; Lerolle DL; Vinceneux P
    Arch Dermatol; 2003 Sep; 139(9):1126-8. PubMed ID: 12975152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.